Click Here for a detailed listing of studies, formatted as a .pdf.

Breast Cancer Studies
Mammary Ductoscopy and Intraductal Biopsy for Women at High Risk for Developing Breast Cancer, for Women Presenting with Spontaneous Nipple Discharge, and for Women Diagnosed with Breast Cancer Undergoing Surgery to the Contralateral Breast

Multi-Center Clinical Study to Determine the Effectiveness and Safety of HEDA™ in the Screening of Women for Breast Cancer

Clinical Evaluation of LS-03M/LS-04R for the Detection of Sentinel Lymph Node Metastasis from Breast Cancer

Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment

GI/Colon
A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence based on Prospectively Determined Molecular Markers

A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU) / Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Cancer

Renal/Urothelial
A Randomized, Double-Blind Phase III Trial of Adjuvant Sunitinib versus Sorafenib versus Placebo in Patients with Resected Renal Cell Carcinoma

A Randomized Phase II Trial of Cetuximab With and Without Weekly Paclitaxel in Patients with Previously Treated Advanced Urothelial Cancer

Head and Neck
A Phase II Study of Single Agent Depsipeptide in Patients with Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Phase III Randomized, Placebo Controlled, Trial of Docetaxel Versus Docetaxel plus ZD1839 (Iressa, Gefitinib) in Performance Status 2 Or Previously Treated Patients With Recurrent Or Metastatic Head and Neck Cancer

Lung
Randomized Phase III Study of Docetaxel or Pemetrexed with or without Cetuximab in Patients with Recurrent or Progressive Non-Small Cell Lung Cancer after Platinum-Based Therapy

SQOL/Fatigue/Other
Survey of Testosterone Levels in a Diverse Set of Male Patients with Hormone-Independent Cancers

Prostate
Phase III Study of Docetaxel and Atrasentan Versus Docetaxel and Placebo for Patients with Advanced Hormone Refractory Prostate Cancer

Pancreatic
A Multinational, Randomized, Double-Blind Study, Comparing the Efficacy of Aflibercept Once Every 2 Weeks versus Placebo in Patients Treated with Gemcitabine for Metastatic Pancreatic Cancer

Phase I-II Dose Finding Trial of Irinotecan With Fixed Doses of 5-Fluorouracil, Cisplatin, and Concomitant Split Course External Beam Radiation For Patients With Untreated Locally Advanced Pancreatic Cancer